-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Organogenesis Holdings Inc. quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from 2017 to Q1 2025.
- Organogenesis Holdings Inc. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2025 was -$1.27M.
- Organogenesis Holdings Inc. annual Deferred Income Tax Expense (Benefit) for 2024 was -$10.7M, a 633% decline from 2023.
- Organogenesis Holdings Inc. annual Deferred Income Tax Expense (Benefit) for 2023 was $2.01M, a 1.62% increase from 2022.
- Organogenesis Holdings Inc. annual Deferred Income Tax Expense (Benefit) for 2022 was $1.98M.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Growth (%)